NCT07027852 My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record
| NCT ID | NCT07027852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Women's College Hospital |
| Condition | Copd |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-01-15 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-01-15 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study Description: My Lung Health Coach (MLHC) is a virtual COPD education and self-management support program delivered through one-on-one sessions with a Certified Respiratory Educator (CRE) over 12 weeks. It includes six sessions that cover essential COPD topics such as: Basic COPD knowledge, Smoking cessation, Medications (inhalers, oxygen), Physical activity, Mental health and wellness, Vaccinations, Symptom self-management, Nutrition, Travel, and Long-term planning (including end-of-life care). The investigators have also developed a companion app to MLHC integrated into the electronic patient record that patients can access through their EPIC MyHealth app on the participants phones, tablets, or desktops. This study will evaluate the feasibility and effectiveness of MLHC and the companion app.
Eligibility Criteria
Inclusion Criteria: 1. Must be deemed to have capacity to provide informed consent; 2. Must sign and date the informed consent form; 3. Stated willingness to comply with all study procedures; 4. Be diagnosed with COPD as per a WCH Respirologist 5. Be 40 years or older 6. Be a current or ex-smoker 7. Preferred but not required: have a history of at least 1 COPD exacerbation (requiring prednisone or antibiotic use, or an urgent healthcare visit of any kind) in the previous 12 months Exclusion Criteria: 1. Experienced a COPD exacerbation in the 4 previous weeks to study enrollment 2. Co-diagnosis of asthma by a WCH Respirologist 3. Significant co-morbidities that could interfere with program participation or terminal illness 4. Unwilling to download and use the Epic Care Companion app and has a unsuitable mobile device to do this 5. Pregnancy
Contact & Investigator
Andrew Kouri, MD
PRINCIPAL INVESTIGATOR
Womens College Hospital
Frequently Asked Questions
Who can join the NCT07027852 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 100 Years, studying Copd. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07027852 currently recruiting?
Yes, NCT07027852 is actively recruiting participants. Contact the research team at andrew.kouri@wchospital.ca for enrollment information.
Where is the NCT07027852 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07027852 clinical trial?
NCT07027852 is sponsored by Women's College Hospital. The principal investigator is Andrew Kouri, MD at Womens College Hospital. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.